BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 35398010)

  • 41. Impact of Malnutrition in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial.
    Scotti A; Coisne A; Granada JF; Driggin E; Madhavan MV; Zhou Z; Redfors B; Kar S; Lim DS; Cohen DJ; Lindenfeld J; Abraham WT; Mack MJ; Asch FM; Stone GW
    J Am Coll Cardiol; 2023 Jul; 82(2):128-138. PubMed ID: 37306651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Leaflet-to-annulus index and residual tricuspid regurgitation following tricuspid transcatheter edge-to-edge repair.
    Tanaka T; Sugiura A; Kavsur R; Vogelhuber J; Öztürk C; Becher MU; Zimmer S; Nickenig G; Weber M
    EuroIntervention; 2022 Jun; 18(2):e169-e178. PubMed ID: 35193837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation-A Systematic Review and Meta-Analysis.
    Rehan ST; Eqbal F; Ul Hussain H; Ali E; Ali A; Ullah I; Ullah W; Ahmed J; Brailovsky Y; Rajapreyar IN; Asghar MS
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt B):102055. PubMed ID: 37652111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcatheter Edge-to-Edge Mitral Valve Repair in Patients With Severe Mitral Regurgitation and Cardiogenic Shock.
    Simard T; Vemulapalli S; Jung RG; Vekstein A; Stebbins A; Holmes DR; Czarnecki A; Hibbert B; Alkhouli M
    J Am Coll Cardiol; 2022 Nov; 80(22):2072-2084. PubMed ID: 36126766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transcatheter tricuspid valve edge-to-edge repair after a heart transplant: a single-centre experience with a novel therapy†.
    Kerbel T; Uyanik-Ünal K; Mach M; Bartunek A; Gökler J; Osorio E; Bartko P; Zuckermann A; Andreas M
    Eur J Cardiothorac Surg; 2023 Jun; 63(6):. PubMed ID: 37255327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction in Right Atrial Pressures Is Associated With Hemodynamic Improvements After Transcatheter Edge-to-Edge Repair of the Tricuspid Valve.
    Mahowald MK; Nishimura RA; Pislaru SV; Mankad SV; Nkomo VT; Padang R; Thaden JJ; Alkhouli M; Guerrero M; Rihal CS; Eleid MF
    Circ Cardiovasc Interv; 2021 Dec; 14(12):e010557. PubMed ID: 34814697
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mitral Valve Transcatheter Edge-to-Edge Repair After TAVR: A Nationwide Analysis.
    Elkaryoni A; Saad M; Darki A; Abdelkarim I; Has P; Hyder ON; Mamdani ST; Sharaf BL; Gordon P; Lopez JJ; Abbott JD; Stone GW
    Am J Cardiol; 2023 Dec; 209():184-189. PubMed ID: 37858596
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tricuspid Regurgitation and Right Ventricular Function in Patients Undergoing Percutaneous Treatment of Mitral Regurgitation.
    Brunner S; Stämpfli SF; Paul M; De Boeck B; Wolfrum M; Moccetti F; Attinger-Toller A; Bossard M; Cuculi F; Matt P; Kobza R; Toggweiler S
    J Invasive Cardiol; 2022 Dec; 34(12):E850-E857. PubMed ID: 36328515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tricuspid regurgitation is a predictor of mortality after percutaneous mitral valve edge-to-edge repair.
    Yzeiraj E; Bijuklic K; Tiburtius C; Witt J; Krause K; Steude J; Hansen L; Rieß FC; Schofer J
    EuroIntervention; 2017 Feb; 12(15):e1817-e1824. PubMed ID: 28117278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardio-hepatic syndrome in patients undergoing mitral valve transcatheter edge-to-edge repair.
    Stolz L; Orban M; Karam N; Lubos E; Wild M; Weckbach L; Stocker TJ; Praz F; Braun D; Löw K; Hausleiter S; Stark K; Doldi P; Tence N; Orban M; Higuchi S; Haum M; Windecker S; Hagl C; Mayerle J; Näbauer M; Kalbacher D; Massberg S; Hausleiter J
    Eur J Heart Fail; 2023 Jun; 25(6):872-884. PubMed ID: 36994662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tricuspid Regurgitation Associated With Ischemic Mitral Regurgitation: Characterization, Evolution After Mitral Surgery, and Value of Tricuspid Repair.
    Navia JL; Elgharably H; Javadikasgari H; Ibrahim A; Koprivanac M; Lowry AM; Blackstone EH; Klein AL; Gillinov AM; Roselli EE; Svensson LG
    Ann Thorac Surg; 2017 Aug; 104(2):501-509. PubMed ID: 28223050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mitral valve gradient changes associate with outcomes of patients undergoing transcatheter edge-to-edge repair.
    Sraya R; Amsalem I; Carasso S; Gilad O; Asher E; Dvir D; Harari E; Glikson M; Marmor D; Shuvy M
    Int J Cardiol; 2024 Apr; 400():131766. PubMed ID: 38211677
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cerebrovascular Events After Transcatheter Edge-to-Edge Repair and Guideline-Directed Medical Therapy in the COAPT Trial.
    Vincent F; Redfors B; Kotinkaduwa LN; Kar S; Lim DS; Mishell JM; Whisenant BK; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
    JACC Cardiovasc Interv; 2023 Jun; 16(12):1448-1459. PubMed ID: 37380226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcatheter edge-to-edge repair of the tricuspid valve: The US experience.
    Sedhom R; Megaly M; Saad M; Elbadawi A; Witzke CF; Garcia S; Latib A; Gafoor SA
    Catheter Cardiovasc Interv; 2022 May; 99(6):1859-1866. PubMed ID: 35362665
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of Residual Mitral Regurgitation on Survival After Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation.
    Higuchi S; Orban M; Stolz L; Karam N; Praz F; Kalbacher D; Ludwig S; Braun D; Näbauer M; Wild MG; Neuss M; Butter C; Kassar M; Petrescu A; Pfister R; Iliadis C; Unterhuber M; Park SD; Thiele H; Baldus S; von Bardeleben RS; Schofer N; Massberg S; Windecker S; Lurz P; Hausleiter J
    JACC Cardiovasc Interv; 2021 Jun; 14(11):1243-1253. PubMed ID: 33992551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age-Related Outcomes After Transcatheter Mitral Valve Repair in Patients With Heart Failure: Analysis From COAPT.
    Song C; Madhavan MV; Lindenfeld J; Abraham WT; Kar S; Lim DS; Grayburn PA; Kapadia SR; Kotinkaduwa LN; Mack MJ; Stone GW
    JACC Cardiovasc Interv; 2022 Feb; 15(4):397-407. PubMed ID: 35093278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thirty-day and one-year outcomes following transcatheter mitral valve edge-to-edge repair versus transapical mitral valve replacement in patients with left ventricular dysfunction.
    Hungerford S; Bart N; Song N; Jansz P; Dahle G; Duncan A; Hayward C; Muller D
    AsiaIntervention; 2023 Mar; 9(1):78-86. PubMed ID: 36936096
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tricuspid edge-to-edge repair for tricuspid valve prolapse and flail leaflet: feasibility in comparison to patients with secondary tricuspid regurgitation.
    Dannenberg V; Bartko PE; Andreas M; Bartunek A; Goncharov A; Gerçek M; Friedrichs K; Hengstenberg C; Rudolph V; Ivannikova M
    Eur Heart J Cardiovasc Imaging; 2024 Feb; 25(3):365-372. PubMed ID: 37861385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two-Year Outcomes for Tricuspid Repair With a Transcatheter Edge-to-Edge Valve Repair From the Transatlantic TRILUMINATE Trial.
    von Bardeleben RS; Lurz P; Sorajja P; Ruf T; Hausleiter J; Sitges M; Da Rocha E Silva J; Näbauer M; Weber M; Tang GHL; Heitkemper M; Ying SW; Trochu JN; Kar S; Hahn RT; Nickenig G;
    Circ Cardiovasc Interv; 2023 Aug; 16(8):e012888. PubMed ID: 37582170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Tricuspid regurgitation: transcatheter treatment by TriClip®].
    Lancellotti P; Lempereur M; Bruls S; Tchana-Sato V; Ancion A; Dulgheru R
    Rev Med Liege; 2022 Oct; 77(10):578-585. PubMed ID: 36226394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.